Health TrialsbyHealthPanel

The Efficacy of Implementing Nurse-performed Ultrasound-guided Peripheral Intravenous Access in Oncology Patients

ConditionSupportive Care
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorFaroese Hospital System

About this trial

The purpose of this study is to investigate the clinical efficacy of nurse-performed ultrasound-guided intravenous access in oncology patients on the oncological outpatient unit in the National Hospital of the Faroe Islands.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Cancer patients admitted to the oncological outpatient unit are eligible for inclusion if they are scheduled for treatment with chemotherapy requiring placement of peripheral intravenous catheter, aged 18 years or older, and reside in the Faroe Islands.

Disqualifiers

Lack of informed consent and mental incapacity.

Trial design

Design model

Factorial

Treatments tested in this trial

  • Ultrasound

    Device

    Ultrasound-guided peripheral intravenous catheter insertion

Treatment groups

40 Participants
are divided into 2 treatment groups
Group A: Ultrasound-guided peripheral intravenous accessExperimental treatment 1 intervention
Group B: Traditional palpation intravenous access techniqueActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

First attempt success rate

Placement of a functional peripheral intravenous catheter on the first attempt. Defined as retraction of the needle, blood in the plastic catheter, smooth insertion of the plastic catheter and subsequent flush with isotonic saline without signs of extravasal placement.

Time frame
The time frame for the outcome measure first attempt succes rate for each participant is estimated 1 hour in the pre-implementation stage and 1 hour in the post-implementation stage.

Secondary outcomes

1

Number of skin punctures

Total number of insertion attempts i.e., number of skin punctures needed to successfully insert a peripheral intravenous catheter

Time frame
The time frame for the outcome measure number of attempts for each participant is estimated 1 hour in the pre-implementation stage and 1 hour in the post-implementation stage.
2

Patient's satisfaction

Arbitrary Likert scale 0-5

Time frame
The time frame for the outcome measure patient´s satisfaction for each participant is estimated 1 hour in the pre-implementation stage and 1 hour in the post-implementation stage.
3

Patient's experience of pain

Numerical Rating Scale (NRS) scale 0-10

Time frame
The time frame for the outcome measure patient´s experience of pain for each participant is estimated 1 hour in the pre-implementation stage and 1 hour in the post-implementation stage.
4

Durability

Is the chemotherpy session completed successfully (yes/no). Defined as intravenous chemotherapy successfully infused with only one peripheral intravenous catheter used.

Time frame
The time frame for the outcome measure durability for each participant is estimated 4 hours in the pre-implementation stage and 4 hours in the post-implementation stage.

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Faroese Hospital System

Lead sponsor

National Hospital of the Faroe Islands

Collaborator

University of the Faroe Islands

Collaborator

University of Aarhus

Collaborator

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: